Nuclear receptors play an important role in transcription regulation.
They bind as homo- or heterodimers to the response elements of their t
arget genes and interact with numerous and diverse partners, e.g. coac
tivator and corepressor proteins, and transcription factors. Many of t
hese processes are ligand-dependent, i.e. binding of natural ligands a
ctivates the nuclear receptor through conformational changes of the pr
otein. Synthetic ligands can be made specific for a particular recepto
r and have the potential for reducing the side-effects of natural liga
nds in pharmaceutical applications. The crystal structures of ligand-b
inding domains of the retinoid receptors have brought the first insigh
t into the spatial organization and the nature of the ligand-induced c
hanges at the atomic level. Furthermore, these structures provide a st
arting point for structure-based drug design of retinoids.